ANITA VARMA: Open Payments
NPI 1760498182 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 79 payments from 15 companies in 2025. Trend: 2023 $1,776 · 2024 $1,876 · 2025 $1,449
Food & beverage: $1,449
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $232 |
| Alkermes, Inc. | 11 | $229 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $192 |
| ABBVIE INC. | 9 | $191 |
| Neurocrine BioSciences, Inc. | 9 | $173 |
| Janssen Pharmaceuticals, Inc | 7 | $124 |
| Vanda Pharmaceuticals Inc. | 5 | $92 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Bausch Health US, LLC | 1 | $25 |
Products named: ARISTADA, REXULTI, CAPLYTA, VRAYLAR, INGREZZA, INVEGA SUSTENNA, COBENFY, HETLIOZ.
Industry payments across TN — which companies pay providers there.
